84 related articles for article (PubMed ID: 20408943)
1. EGFRvIII mRNA detection in the serum of patients with hepatocellular carcinoma.
Zhou M; Gong B; Gu J; Li Z
Liver Int; 2010 Jul; 30(6):925-7. PubMed ID: 20408943
[No Abstract] [Full Text] [Related]
2. Lack of specificity of albumin-mRNA-positive cells as a marker of circulating hepatoma cells.
Müller C; Petermann D; Pfeffel F; Oesterreicher C; Függer R
Hepatology; 1997 Apr; 25(4):896-9. PubMed ID: 9096594
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte growth factor, transforming growth factor alpha, and their receptors as combined markers of prognosis in hepatocellular carcinoma.
Daveau M; Scotte M; François A; Coulouarn C; Ros G; Tallet Y; Hiron M; Hellot MF; Salier JP
Mol Carcinog; 2003 Mar; 36(3):130-41. PubMed ID: 12619035
[TBL] [Abstract][Full Text] [Related]
4. Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma.
Miura N; Maeda Y; Kanbe T; Yazama H; Takeda Y; Sato R; Tsukamoto T; Sato E; Marumoto A; Harada T; Sano A; Kishimoto Y; Hirooka Y; Murawaki Y; Hasegawa J; Shiota G
Clin Cancer Res; 2005 May; 11(9):3205-9. PubMed ID: 15867214
[TBL] [Abstract][Full Text] [Related]
5. Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution.
Hsu HC; Cheng W; Lai PL
Cancer Res; 1997 Nov; 57(22):5179-84. PubMed ID: 9371521
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor mRNA expression in peripheral blood of bladder cancer patients: a potential marker to detect treatment failure.
Gazzaniga P; Gradilone A; Frati L; Aglianò AM
Clin Cancer Res; 2001 Dec; 7(12):4288-9. PubMed ID: 11751531
[No Abstract] [Full Text] [Related]
7. Detection of albumin messenger RNA in blood is not restricted to hepatocellular carcinoma.
Ijzermans JN; Bac DJ; Niesters BG
Hepatology; 1996 Jun; 23(6):1708-9. PubMed ID: 8675200
[No Abstract] [Full Text] [Related]
8. Epidermal growth factor receptor vIII enhances tumorigenicity and resistance to 5-fluorouracil in human hepatocellular carcinoma.
Wang H; Jiang H; Zhou M; Xu Z; Liu S; Shi B; Yao X; Yao M; Gu J; Li Z
Cancer Lett; 2009 Jun; 279(1):30-8. PubMed ID: 19217205
[TBL] [Abstract][Full Text] [Related]
9. The gene expression level of transforming growth factor-beta (TGF-beta) as a biological prognostic marker of hepatocellular carcinoma.
Ikeguchi M; Iwamoto A; Taniguchi K; Katano K; Hirooka Y
J Exp Clin Cancer Res; 2005 Sep; 24(3):415-21. PubMed ID: 16270528
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma: susceptibility markers.
Blum HE
IARC Sci Publ; 2001; 154():241-4. PubMed ID: 11220663
[TBL] [Abstract][Full Text] [Related]
11. [Molecular markers for early diagnosis of hepatocellular carcinoma].
Yao DF
Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):492. PubMed ID: 15329213
[No Abstract] [Full Text] [Related]
12. Identification of ROBO1 as a novel hepatocellular carcinoma antigen and a potential therapeutic and diagnostic target.
Ito H; Funahashi S; Yamauchi N; Shibahara J; Midorikawa Y; Kawai S; Kinoshita Y; Watanabe A; Hippo Y; Ohtomo T; Iwanari H; Nakajima A; Makuuchi M; Fukayama M; Hirata Y; Hamakubo T; Kodama T; Tsuchiya M; Aburatani H
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3257-64. PubMed ID: 16740745
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor expression and gene copy number in fibrolamellar hepatocellular carcinoma.
Buckley AF; Burgart LJ; Kakar S
Hum Pathol; 2006 Apr; 37(4):410-4. PubMed ID: 16564914
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor mRNA in peripheral blood of patients with pancreatic, lung, and colon carcinomas detected by RT-PCR.
Clarke LE; Leitzel K; Smith J; Ali SM; Lipton A
Int J Oncol; 2003 Feb; 22(2):425-30. PubMed ID: 12527944
[TBL] [Abstract][Full Text] [Related]
16. A marker for predictions of HCC recurrence postresection?
Blendis L; Wong F
Gastroenterology; 2002 Dec; 123(6):2152-3. PubMed ID: 12454875
[No Abstract] [Full Text] [Related]
17. [The application of serum tumor markers in the diagnosis of hepatocellular carcinoma].
Liao HY
Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):379-80. PubMed ID: 15918977
[No Abstract] [Full Text] [Related]
18. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q
ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of plasma TGF-beta1 and circulating TGF-beta1 mRNA in diagnosis of hepatocellular carcinoma.
Dong ZZ; Yao DF; Yao M; Qiu LW; Zong L; Wu W; Wu XH; Yao DB; Meng XY
Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):288-95. PubMed ID: 18522884
[TBL] [Abstract][Full Text] [Related]
20. Development of a novel assay to quantify serum human telomerase reverse transcriptase messenger RNA and its significance as a tumor marker for hepatocellular carcinoma.
Miura N; Maruyama S; Oyama K; Horie Y; Kohno M; Noma E; Sakaguchi S; Nagashima M; Kudo M; Kishimoto Y; Kawasaki H; Hasegawa J; Shiota G
Oncology; 2007; 72 Suppl 1():45-51. PubMed ID: 18087181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
